<unk>  (RGX/E2/NETA), sold under the brand name Myfembree, is a fixed-dose combination hormonal medication which is used for the treatment of heavy menstrual bleeding associated with uterine leiomyomas (fibroids) in premenopausal women. It contains<unk> , an orally active gonadotropin-releasing hormone antagonist (GnRH antagonist), estradiol (E2), an estrogen, and norethisterone acetate (NETA), a progestin. The most common side effects include hot flushes, hyperhidrosis or night sweats, uterine bleeding, alopecia (hair loss or hair thinning), and decreased libido (decreased interest in sex).<unk>  was approved for medical use in the United States in May 2021.
Relugolix/estradiol/norethisterone acetate
Elagolix/estradiol/norethindrone acetate
Mestranol/norethisterone
Estradiol valerate/norethisterone enantate
Testosterone propionate/testosterone cypionate/prasterone
Estradiol undecylate/norethisterone enanthate
Estradiol enantate/algestone acetophenide
Ethinylestradiol sulfonate/norethisterone acetate